Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,100
+$3,331 QoQ
Shares Held
36,053
+32.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 170 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $248,215,917 across 22 Drug Manufacturers - Specialty & Generic names. AKBA ranks #22 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,374,683 | $69,469,966 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
371,568 | $62,624,070 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
79,123 | $42,871,215 | |
| 4 | ZTS |
Zoetis Inc.
|
531,415 | $38,187,481 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
465,714 | $11,461,221 | |
| 6 | PRGO |
PERRIGO Co plc
|
435,648 | $4,526,382 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,850 | $3,891,695 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
76,441 | $2,767,164 |
All Filings in AKBA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,100 | 36,053 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,769 | 27,172 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,711 | 15,970 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,582 | 14,499 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,671 | 15,569 | Shares | Sole | 2025-08-14 | |
| 2021-06-30 | $72,749 | 19,195 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||